PRME prime Medicine announces U.S. FDA clearance of investigational new drug application for pm577a in h1069q-mutated Wilson disease
Story updates
08:08:44 PM UTC
SquawkNews
PRME Prime Medicine Announces U.S. FDA Clearance of Investigational New Drug Application for PM577a in H1069Q-mutated Wilson Disease
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.